Original Research
Published on 11 Jul 2025
AMPs inhibit the proliferation, migration, and invasion of lung cancer via the CHRM3/PI3K/AKT and CHRM3/MAPK pathways
in Pharmacology of Anti-Cancer Drugs
- 193 views
Original Research
Published on 11 Jul 2025
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 08 Jul 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 08 Jul 2025
in Pharmacology of Anti-Cancer Drugs
Editorial
Accepted on 30 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 30 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 30 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 25 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Accepted on 23 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 18 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Review
Published on 18 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 12 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Clinical Trial
Published on 10 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 06 Jun 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 May 2025
in Pharmacology of Anti-Cancer Drugs
Correction
Published on 29 May 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 May 2025
in Pharmacology of Anti-Cancer Drugs